Upon viral entry through this route, ACE2 suppression causes overactivation of the renin angiotensin system, associated with vasoconstriction, inflammation, edema and fibrosis, all of which contributing to COVID-19 disease severity (De Spiegeleer et al, 2020; Silhol et al, 2020). The gene discussed is ACE2; the disease is COVID-19.